CTMX — CytomX Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for CytomX Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	296	316	305	194	175
Net Total Accounts Receivable
Net Total Receivables	0.013	0.798	0.79	36	3.43
Prepaid Expenses
Total Current Assets	303	324	310	237	183
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32.8	29.4	25.3	21	16.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	341	359	339	261	202
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	85.6	101	77.9	153	156
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	290	309	340	347	249
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	51.1	49.8	-0.459	-85.8	-47.4
Total Liabilities & Shareholders' Equity	341	359	339	261	202
Total Common Shares Outstanding